In continuation of our previous work targeting breast cancer via Pin1 inhibition [33], herein we design new benzimidazoles by altering the carboxylic group of compound II with different substitutions at the 2-position to give new products with expected improved activity. The gene discussed is PIN1; the disease is breast carcinoma.